位置:首页 > 蛋白库 > FR1L5_MOUSE
FR1L5_MOUSE
ID   FR1L5_MOUSE             Reviewed;        2038 AA.
AC   P0DM40; M1J7P7;
DT   26-JUN-2013, integrated into UniProtKB/Swiss-Prot.
DT   26-JUN-2013, sequence version 1.
DT   03-AUG-2022, entry version 54.
DE   RecName: Full=Fer-1-like protein 5;
GN   Name=Fer1l5;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH EHD1 AND EHD2,
RP   SUBCELLULAR LOCATION, INDUCTION, MUTAGENESIS OF ASN-206 AND
RP   206-ASN--PHE-208, AND TISSUE SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=21177873; DOI=10.1074/jbc.m110.157222;
RA   Posey A.D. Jr., Pytel P., Gardikiotes K., Demonbreun A.R., Rainey M.,
RA   George M., Band H., McNally E.M.;
RT   "Endocytic recycling proteins EHD1 and EHD2 interact with fer-1-like-5
RT   (Fer1L5) and mediate myoblast fusion.";
RL   J. Biol. Chem. 286:7379-7388(2011).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
CC   -!- FUNCTION: Plays a role in myoblast fusion; probable mediator of
CC       endocytic recycling for membrane trafficking events during myotube
CC       formation. {ECO:0000269|PubMed:21177873}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00041};
CC   -!- SUBUNIT: Interacts (via second C2 domain) with EHD1 and EHD2.
CC       {ECO:0000269|PubMed:21177873}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:21177873}.
CC       Membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.
CC       Note=Colocalizes with EHD1 and EHD2 at the plasma membrane in myoblasts
CC       and myotubes. Localizes into foci at the plasma membrane.
CC   -!- TISSUE SPECIFICITY: Expressed in differentiating myoblasts and
CC       myotubes. {ECO:0000269|PubMed:21177873}.
CC   -!- INDUCTION: Up-regulated during myotube formation.
CC       {ECO:0000269|PubMed:21177873}.
CC   -!- SIMILARITY: Belongs to the ferlin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KC440916; AGE83049.1; -; mRNA.
DR   EMBL; GL456084; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS78562.1; -.
DR   RefSeq; NP_001264005.1; NM_001277076.1.
DR   AlphaFoldDB; P0DM40; -.
DR   SMR; P0DM40; -.
DR   PhosphoSitePlus; P0DM40; -.
DR   jPOST; P0DM40; -.
DR   PRIDE; P0DM40; -.
DR   ProteomicsDB; 267515; -.
DR   Antibodypedia; 73876; 15 antibodies from 6 providers.
DR   Ensembl; ENSMUST00000179162; ENSMUSP00000142130; ENSMUSG00000037432.
DR   GeneID; 100534273; -.
DR   KEGG; mmu:100534273; -.
DR   UCSC; uc033fip.1; mouse.
DR   CTD; 90342; -.
DR   MGI; MGI:3616091; Fer1l5.
DR   VEuPathDB; HostDB:ENSMUSG00000037432; -.
DR   GeneTree; ENSGT00940000161318; -.
DR   HOGENOM; CLU_001183_2_1_1; -.
DR   OMA; SEGWEYG; -.
DR   OrthoDB; 20162at2759; -.
DR   BioGRID-ORCS; 100534273; 1 hit in 64 CRISPR screens.
DR   PRO; PR:P0DM40; -.
DR   Proteomes; UP000000589; Chromosome 1.
DR   RNAct; P0DM40; protein.
DR   Bgee; ENSMUSG00000037432; Expressed in spermatid and 60 other tissues.
DR   ExpressionAtlas; P0DM40; baseline and differential.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0030315; C:T-tubule; IBA:GO_Central.
DR   GO; GO:0005509; F:calcium ion binding; IBA:GO_Central.
DR   GO; GO:0005544; F:calcium-dependent phospholipid binding; IBA:GO_Central.
DR   GO; GO:0002281; P:macrophage activation involved in immune response; IBA:GO_Central.
DR   GO; GO:0061025; P:membrane fusion; IBA:GO_Central.
DR   GO; GO:0002280; P:monocyte activation involved in immune response; IBA:GO_Central.
DR   GO; GO:0007520; P:myoblast fusion; IEA:InterPro.
DR   GO; GO:0050765; P:negative regulation of phagocytosis; IBA:GO_Central.
DR   GO; GO:0007009; P:plasma membrane organization; IBA:GO_Central.
DR   GO; GO:0001778; P:plasma membrane repair; IBA:GO_Central.
DR   GO; GO:0033292; P:T-tubule organization; IBA:GO_Central.
DR   GO; GO:0006906; P:vesicle fusion; IBA:GO_Central.
DR   CDD; cd04011; C2B_Ferlin; 1.
DR   CDD; cd04017; C2D_Ferlin; 1.
DR   CDD; cd04037; C2E_Ferlin; 1.
DR   CDD; cd08374; C2F_Ferlin; 1.
DR   Gene3D; 2.60.40.150; -; 6.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR037720; C2B_Ferlin.
DR   InterPro; IPR037723; C2D_Ferlin.
DR   InterPro; IPR037724; C2E_Ferlin.
DR   InterPro; IPR037725; C2F_Ferlin.
DR   InterPro; IPR029997; Fer1L5.
DR   InterPro; IPR012968; FerIin_dom.
DR   InterPro; IPR037721; Ferlin.
DR   InterPro; IPR012560; Ferlin_A-domain.
DR   InterPro; IPR012561; Ferlin_B-domain.
DR   InterPro; IPR032362; Ferlin_C.
DR   InterPro; IPR006614; Peroxin/Ferlin.
DR   PANTHER; PTHR12546; PTHR12546; 1.
DR   PANTHER; PTHR12546:SF34; PTHR12546:SF34; 1.
DR   Pfam; PF00168; C2; 7.
DR   Pfam; PF08165; FerA; 1.
DR   Pfam; PF08150; FerB; 1.
DR   Pfam; PF16165; Ferlin_C; 1.
DR   SMART; SM00239; C2; 6.
DR   SMART; SM00694; DysFC; 2.
DR   SMART; SM00693; DysFN; 2.
DR   SMART; SM01200; FerA; 1.
DR   SMART; SM01201; FerB; 1.
DR   SMART; SM01202; FerI; 1.
DR   SUPFAM; SSF49562; SSF49562; 7.
DR   PROSITE; PS50004; C2; 7.
PE   1: Evidence at protein level;
KW   Calcium; Cell membrane; Membrane; Metal-binding; Reference proteome;
KW   Repeat; Transmembrane; Transmembrane helix.
FT   CHAIN           1..2038
FT                   /note="Fer-1-like protein 5"
FT                   /id="PRO_0000422647"
FT   TRANSMEM        1961..1981
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          1..100
FT                   /note="C2 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          145..265
FT                   /note="C2 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          307..424
FT                   /note="C2 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          1055..1186
FT                   /note="C2 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          1225..1345
FT                   /note="C2 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          1467..1587
FT                   /note="C2 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          1705..1853
FT                   /note="C2 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         1502
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         1502
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         1508
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         1557
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         1557
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         1558
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         1559
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         1559
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         1565
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         1824
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         1827
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         1830
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   MUTAGEN         206..208
FT                   /note="NPF->SPL: Reduces interaction with EHD2."
FT                   /evidence="ECO:0000269|PubMed:21177873"
FT   MUTAGEN         206
FT                   /note="N->C: Reduces interaction with EHD2."
FT                   /evidence="ECO:0000269|PubMed:21177873"
FT   CONFLICT        1025
FT                   /note="E -> K (in Ref. 1; AGE83049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1161
FT                   /note="N -> K (in Ref. 1; AGE83049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1310
FT                   /note="V -> A (in Ref. 1; AGE83049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1556
FT                   /note="F -> S (in Ref. 1; AGE83049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1582
FT                   /note="F -> S (in Ref. 1; AGE83049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1739
FT                   /note="T -> A (in Ref. 1; AGE83049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1803
FT                   /note="W -> R (in Ref. 1; AGE83049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1831
FT                   /note="F -> I (in Ref. 1; AGE83049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1975
FT                   /note="L -> H (in Ref. 1; AGE83049)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2038 AA;  235837 MW;  FCD0D9EAC76C65E9 CRC64;
     MLRVVVESAS INPPLSTTPK AFVTVYFRDM MKRTRVEEGH DPIWNETLIW HLWNQPLEND
     SFLKVILQDS VSKKKERFIG LATVPLKRLA QRPKEVMFVR DLILLNHSMK PTNCTVTLHV
     AQIYDQDTEM TGNEELLGST VNEVTQKKLM VSGLPMHRAL ASKPQHFQVR VKVFEARQLL
     GNNIKPVVKV NIADQQHLTR IKMGNNPFFN EIFFQNFHEV PAKFFEENIS IEVVDSAASR
     SKAEIGRFQT DIGFIYHSPG HTLLRKWLGL CQRNKTTSGV RGYLKVTICA LGVGDQALVD
     QKLPYEQNTR VQIFKSKEVP VSLAYLQFFI YCAEDLHFGT HKSATPVLEV ELIGDKLRTK
     PQNPSDNPIW NQILTFQIQL PCLSSYIKFR VMDCSKYKCQ DEIGSASLCL SQISSTGEEI
     QGMYSGFLPC FGPSFLTLRG GKKPPFRTSE EGTCIMDAVQ HGLAYRGRIF VEIVTKIKSQ
     QDSVMKDLSQ EVTQVEMQYY RQKYGLCVIF LSCTMMPKFK DLIQFEVSMG HYGNKTDPNY
     KPLVSTTQYS PVIYDGTTYH YVPWYNTKPV VAVTSNWEDV GFRMNCLNLL HITRDRLKTN
     LDILKSIRNP RDPALLQQWE KLLKELQEDC RRPLPCMTDQ PRANSLDRNK WQLRSQLLQQ
     LAQMAKEAKP VNMVGTAKEW LHRLNAVIPE PQESLPDVLI WLMSRQQRVA YARVPAHTVL
     FSPAGPLSSG KFCGKIQNIL LQYPEGEGQD TFPASLRVCM WLGNVKYSKN LKLLQQGSMV
     VYAETYENQA KTRDDWGQQG LYHCPNFSDV MGRKALPKTD FKAPPGWHWK DDWVVEPQRR
     LLLDIDINKS QVLEEVYENQ LRNATGAWVP AAIPNTDVNG QPVEALENVK CPQGWHFKKN
     WIVKLNHAVD SEGWEYGVGI PPSGLPQIWN SVEKTYHSCR RRRWVRVRFR NHKELGQERS
     QEQETLSFLQ MQDLSEEGKE GWEYGTFDSR FHLDPQPTSR FRRRCWHRQL APNKDRGVAS
     IFLLEGSLAV EQKDQPRKEM EKTRSWQPWK DLRHTPEDPR IPTTPFIYYI LNKPHYYQLF
     CYIYQARNLM YNQILTFQEP FIQVVFLNHS LCTQTLRSSA APTWSQSIIF QHLLLFEDPK
     DTRENPPLVV LELWQHDSRG NKILWGRSMW PPVVWLGLQD WVFTPLRWHP LVRELGEEEG
     EILASCELIL ETQKLKELHP PILSIPCKDG IYLLPKNIQP TMKMMAIEIM AWGLRNMTKV
     RYPQLLLECG GESLKTEPIS NFQENPNFPT STFFFTVFMP LEETHAQPLV VKVVDNQEYG
     QQIVVGQANI DFLQPYFCDP WSLNYTTVKL PTLSVKKPDT FLDFVYKKFW FDSSKDEEVY
     EEEVDWWSKL FWATGDADKS LNYNHKSYHT LKVYDCELEA VLTFKGLQDF CQTFKLYQEK
     PKVDSPVVGE FKGLFRIYPF PEDPEAPKPP RQFSAWPEIE DFPQMCLVRV YLIRAINLQP
     QDYNGLCDPY VILKLGQTKL GSRDSYYPNT LDPIFGMMYE LTCNIPLEKD LEIQLFDFDL
     ITADDEIGST VIDLENRLLS GFGARCGLSK SYCKSGPFKW RDQMTPSYLL YRYAKQKGLP
     PPVFDLEGDS LYYNGETFKL QSFESAPPTY KHLGPKKERL ALYILNTQGL VPEHVETRTL
     HSNSQPGIDQ GKIQMWVDIF PKMLGPPGPQ VNISPRKPKR YQLRCIIWST AEVDLVQETF
     SKEKMSDIYV KGWLFGLEED TQKTDVHYHS LTGEATFNWR FIFTMDYLTT ERACVQSQKD
     YIWSLDPTST KFPARLMIQI WDNDFFSPDD FLGVLELDLS DMPLPAQNIK QCSLKMMETD
     SKWPFTPQKR ISLFKKTNVT GWWPCQVLDG DKWRLSGKVK MTLEMLSERE ALIRPAGRGQ
     SEPNQFPMLH PPERNDSFLL WYQSPIKNFC YAVCKRYRSK IICLVVTLVI GFILLNFVYS
     APSYFAMNWI KPQLRLSSPI KIVNLIGTVN TSNINSSILT MEGSTYHASH VFPEAPAP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024